Successful Treatment of Long-Term Severe Progressive Interstitial Pneumonia with Low-Dose Corticosteroid and Azathioprine in a Patient with Diffuse Systemic Sclerosis

<table>Clinical course. TLC: total lung capacity, VC: vital capacity, FVC: forced vital capacity, FEV1<i>/</i>FVC: forced expiratory volume in 1s/forced vital capacity, DLCo: carbon monoxide diffusing capacity, and NT: not tested.</table>

Case Reports in Rheumatology

fig1

Figure 1

Figure 1: Successful Treatment of Long-Term Severe Progressive Interstitial Pneumonia with Low-Dose Corticosteroid and Azathioprine in a Patient with Diffuse Systemic Sclerosis 

Figure 1 | Successful Treatment of Long-Term Severe Progressive Interstitial Pneumonia with Low-Dose Corticosteroid and Azathioprine in a Patient with Diffuse Systemic Sclerosis 